Sherbrooke Park Advisers’s Patterson-UTI PTEN Stock Holding History

Sherbrooke Park Advisers’s Portfolio PTEN Stock Details PTEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-15,366	Closed	-$166K	–	971
2023 Q4	$166K	Buy	+15,366	New	+$187K	0.08%	352

Other funds holding PTEN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Sherbrooke Park Advisers's PTEN Position: Q1 2024 in Review

Sherbrooke Park Advisers sold out of Patterson-UTI (PTEN) in Q1 2024, closing a stake of 15,366 shares — an estimated $166K sold.

Sherbrooke Park Advisers first reported a position in PTEN in Q4 2023 and held it in 1 quarter. The position peaked at $166K in Q4 2023. 368 funds tracked by Wall St. Rank hold PTEN as of Q1 2024.

Sherbrooke Park Advisers reported no remaining Patterson-UTI position as of Q1 2024 after selling out during the quarter.
Sherbrooke Park Advisers sold 15,366 Patterson-UTI shares in Q1 2024, an estimated $166K.
Sherbrooke Park Advisers first reported a position in Patterson-UTI in Q4 2023 and held it in 1 quarter.
Sherbrooke Park Advisers's Patterson-UTI position peaked at $166K in Q4 2023.
368 funds tracked by Wall St. Rank held Patterson-UTI as of Q1 2024.

Based on Sherbrooke Park Advisers's 13F filing for Q1 2024, filed 15 May 2024.